Efficacy and Safety of AbobotulinumtoxinA in Pediatric Lower Limb Spasticity: 2nd Interim Results From a Phase IV, Prospective, Observational, Multicenter Study

被引：0
|
作者：
Gormley, Mark [1 ]
Dabrowski, Edward [2 ,3 ]
Tilton, Ann [4 ,5 ]
Christian, Asare [6 ]
Evans, Sarah Helen [7 ]
Maisonobe, Pascal [8 ]
Wietek, Stefan [9 ]
机构：
[1] Gillette Childrens Specialty Healthcare, St Paul, MN USA
[2] Oakland Univ, Sch Med, Grosse Pointe, MI USA
[3] Beaumont Hosp, Grosse Pointe, MI USA
[4] LSUHSC, New Orleans, LA USA
[5] Childrens Hosp New Orleans, New Orleans, LA USA
[6] Good Shepherd Rehabil Hosp, Allentown, PA USA
[7] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[8] Ipsen, Boulogne, France
[9] Ipsen, Cambridge, MA USA
来源：
NEUROLOGY | 2021年 / 96卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1875
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19
    Huang, Mingxing
    Li, Man
    Xiao, Fei
    Pang, Pengfei
    Liang, Jiabi
    Tang, Tiantian
    Liu, Shaoxuan
    Chen, Binghui
    Shu, Jingxian
    You, Yingying
    Li, Yang
    Tang, Meiwen
    Zhou, Jianhui
    Jiang, Guanmin
    Xiang, Jingfen
    Hong, Wenxin
    He, Songmei
    Wang, Zhaoqin
    Feng, Jianhua
    Lin, Changqing
    Ye, Yinong
    Wu, Zhilong
    Li, Yaocai
    Zhong, Bei
    Sun, Ruilin
    Hong, Zhongsi
    Liu, Jing
    Chen, Huili
    Wang, Xiaohua
    Li, Zhonghe
    Pei, Duanqing
    Tian, Lin
    Xia, Jinyu
    Jiang, Shanping
    Zhong, Nanshan
    Shan, Hong
    NATIONAL SCIENCE REVIEW, 2020, 7 (09) : 1428 - 1436
  • [32] Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19
    Mingxing Huang
    Man Li
    Fei Xiao
    Pengfei Pang
    Jiabi Liang
    Tiantian Tang
    Shaoxuan Liu
    Binghui Chen
    Jingxian Shu
    Yingying You
    Yang Li
    Meiwen Tang
    Jianhui Zhou
    Guanmin Jiang
    Jingfen Xiang
    Wenxin Hong
    Songmei He
    Zhaoqin Wang
    Jianhua Feng
    Changqing Lin
    Yinong Ye
    Zhilong Wu
    Yaocai Li
    Bei Zhong
    Ruilin Sun
    Zhongsi Hong
    Jing Liu
    Huili Chen
    Xiaohua Wang
    Zhonghe Li
    Duanqing Pei
    Lin Tian
    Jinyu Xia
    Shanping Jiang
    Nanshan Zhong
    Hong Shan
    National Science Review, 2020, 7 (09) : 1428 - 1436
  • [33] REGIONAL PATTERNS OF TOCILIZUMAB USE, EFFICACY, AND SAFETY IN PATIENTS WITH RHEUMATOID ARTHRITIS: INTERIM RESULTS FROM A MULTINATIONAL OBSERVATIONAL STUDY
    Haraoui, B.
    Casado, G.
    Theander, E.
    Czirjak, L.
    Taylor, A.
    Mikes, E.
    Reiss, W.
    Caporali, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1042 - 1043
  • [34] Evaluation of Efficacy and Safety of Mycophenolate Sodium in Patients With De Novo and Maintenance Renal Transplantation: Results of a Multicenter, Prospective, Observational Study
    Arinsoy, T.
    Uslu, A.
    Mir, S.
    Titiz, I.
    Gonenc, F.
    Celik, A.
    Apaydin, S.
    Kacar, S.
    Guvence, N.
    Turkmen, A.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (03) : 826 - 832
  • [35] IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study
    Christina Marciniak
    Michael C. Munin
    Allison Brashear
    Bruce S. Rubin
    Atul T. Patel
    Jaroslaw Slawek
    Angelika Hanschmann
    Reinhard Hiersemenzel
    Elie P. Elovic
    Advances in Therapy, 2019, 36 : 187 - 199
  • [36] IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study
    Marciniak, Christina
    Munin, Michael C.
    Brashear, Allison
    Rubin, Bruce S.
    Patel, Atul T.
    Slawek, Jaroslaw
    Hanschmann, Angelika
    Hiersemenzel, Reinhard
    Elovic, Elie P.
    ADVANCES IN THERAPY, 2019, 36 (01) : 187 - 199
  • [37] Interim Efficacy and Safety Results from the Phase 2 NURTURE Study Evaluating Nusinersen in Presymptomatic Infants with Spinal Muscular Atrophy
    De Vivo, Darryl C.
    Hwu, Wuh-Liang
    Reyna, Sandra P.
    Farwell, Wildon
    Gheuens, Sarah
    Sun, Peng
    Zhong, Zhenshao John
    Su, John
    Schneider, Eugene
    Bertini, Enrico
    NEUROLOGY, 2017, 88
  • [38] Safety of AbobotulinumtoxinA (Dysport) in Children Aged 2-17 Years Old with Lower Limb Spasticity Due to Cerebral Palsy: Data from Clinical Trials and Pharmacovigilance Reporting
    Gormley, M.
    Tilton, A.
    Matthews, D.
    Mahmoud, A.
    Picaut, P.
    Snyder, D.
    Delgado, M.
    ANNALS OF NEUROLOGY, 2016, 80 : S370 - S370
  • [39] Rituximab efficacy and. safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura:: results of a prospective multicenter phase 2 study
    Godeau, Bertrand
    Porcher, Raphael
    Fain, Olivier
    Lefrere, Francois
    Fenaux, Pierre
    Cheze, Stephane
    Vekhoff, Anne
    Chauveheid, Marie-Paule
    Stirnemann, Jerome
    Galicier, Lionel
    Bourgeois, Emmanuelle
    Haiat, Stephanie
    Varet, Bruno
    Leporrier, Michel
    Papo, Thomas
    Khellaf, Mehdi
    Michel, Marc
    Bierling, Philippe
    BLOOD, 2008, 112 (04) : 999 - 1004
  • [40] Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders:: results of a prospective multicenter phase 2 study
    Choquet, S
    Leblond, V
    Herbrecht, R
    Socié, G
    Stoppa, AM
    Vandenberghe, P
    Fischer, A
    Morschhauser, F
    Salles, G
    Feremans, W
    Vilmer, E
    Peraldi, MN
    Lang, P
    Lebranchu, Y
    Oksenhendler, E
    Garnier, JL
    Lamy, T
    Jaccard, A
    Ferrant, A
    Offner, F
    Hermine, O
    Moreau, A
    Fafi-Kremer, S
    Morand, P
    Chatenoud, L
    Berriot-Varoqueaux, N
    Bergougnoux, L
    Milpied, N
    BLOOD, 2006, 107 (08) : 3053 - 3057
12345